A university tested a new advising script in one office because the trial was limited, reversible, and measured before wider adoption. Another office proposes a similarly limited trial that can be stopped and evaluated. The first trial supports allowing the second, though not yet adopting the script everywhere. Which choice matches a reversible-pilot analogy and preserves the limited scope of the conclusion?